Cargando…
Risk of Opioid Overdose Associated With Concomitant Use of Oxycodone and Selective Serotonin Reuptake Inhibitors
IMPORTANCE: Some selective serotonin reuptake inhibitors (SSRIs) inhibit the enzymes responsible for the metabolism of oxycodone, a potent prescription opioid. The clinical consequences of this interaction on the risk of opioid overdose have not been elucidated. OBJECTIVE: To compare opioid overdose...
Autores principales: | Yunusa, Ismaeel, Gagne, Joshua J., Yoshida, Kazuki, Bykov, Katsiaryna |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Medical Association
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8874341/ https://www.ncbi.nlm.nih.gov/pubmed/35201310 http://dx.doi.org/10.1001/jamanetworkopen.2022.0194 |
Ejemplares similares
-
Risk of mortality with concomitant use of tamoxifen and selective serotonin reuptake inhibitors: multi-database cohort study
por: Donneyong, Macarius M, et al.
Publicado: (2016) -
Reasons for Discontinuation or Change of Selective Serotonin Reuptake Inhibitors in Online Drug Reviews
por: Golder, Su, et al.
Publicado: (2023) -
Sentiment Analysis of Online Reviews for Selective Serotonin Reuptake Inhibitors and Serotonin–Norepinephrine Reuptake Inhibitors
por: Compagner, Chad, et al.
Publicado: (2021) -
Onset of Transient Sadness Following the Concomitant Use of a Triptan and
Selective Serotonin Reuptake Inhibitor/Serotonin Norepinephrine Reuptake Inhibitors
Therapy: A Case Report
por: Meng, Yuki, et al.
Publicado: (2021) -
Comparison of the neurobiological effects of
attribution retraining group therapy with those of selective serotonin reuptake
inhibitors
por: Wang, C., et al.
Publicado: (2013)